Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024Kidney International ReportsOpen Access

WCN24-1037 Minimal change glomerulonephritis steroid-dependent nephrotic syndrome treated with Rituximab

View Full Paper
Ask AI
Bookmark
Share

Authors

FCFABRIZIO CRISTIANOUniversity of Chieti-Pescara

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

FABRIZIO CRISTIANO (2024) studied this question.

synapsesocial.com/papers/68e7115bb6db64358768a198https://doi.org/10.1016/j.ekir.2024.02.311
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Minimal Change Disease2016 · 559 citations
  2. 2TREATMENT OF MINIMAL CHANGE DISEASE IN ADULTS: CURRENT PRACTICE AND FUTURE DIRECTIONS – A NARRATIVE LITERATURE REVIEW2025
  3. 3Clinical characteristics and outcomes of adults with minimal change disease: A retrospective, cross-sectional study2026
  4. 4Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult2024 · 8 citations
  5. 5When Minimal Becomes Massive: A Case Report of Childhood-Onset Minimal Change Disease Marching to End Stage Renal Disease Despite Modern Immunotherapy2026